About Neomi Pharmaceuticals Private Limited
Data last updated:
Neomi Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2016PTC272811. Its GSTIN is 27AAFCN1442H1ZM (Maharashtra).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Jetal Amit Sota and Amit Rajnikant Sota.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.11 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹44.68 Lakh (net margin 1.6%) and EBITDA of ₹72.74 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 60% over five years.
The company is associated with 1 brand: Neomi Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neomipharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address3rd Floor O – 302A & O – 302B Runwal R – Square, L.B.S. Marg Near Canara Bank Atm Mulund West, Mumbai, Maharashtra, India – 400080
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Neomi Pharmaceuticals Private Limited
The main business activity of Neomi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Neomi Pharmaceuticals Private Limited FY 2025 filings available
Neomi Pharmaceuticals Private Limited reported revenue of ₹27.11 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Neomi Pharmaceuticals Private Limited
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 60%. EBITDA fell 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Neomi Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹27.11 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹72.74 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹44.68 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Neomi Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neomi Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nexus Lifecare Private Limited | ₹27.24 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Mumbai, Maharashtra, India |
| Sun Moon Pharmaceuticals Private Limited | ₹27.19 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Boisar, Maharashtra, India |
| Hiya Healthcare Private Limited | ₹27.19 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Bhiwandi, Maharashtra, India |
| Cibeles Pharmaceuticals Private Limited | ₹27.15 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Mumbai, Maharashtra, India |
| Dipali Enterprises Private Limited | ₹27.13 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Neomi Pharmaceuticals Private Limited this company | ₹27.11 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Izek Healthcare Private Limited | ₹27.1 Cr (FY 2025) | •••• | •••• | 56.0% | •••• | New Delhi, Delhi, India |
| Ism Corporation Private Limited | ₹27.06 Cr (FY 2025) | •••• | •••• | 513.0% | •••• | New Delhi, Delhi, India |
| Aditya Generic(Drugs) Private Limited | ₹26.96 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Tezpur, Assam, India |
| Elikem Pharmaceuticals Private Limited | ₹26.94 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Kalol, Gujarat, India |
| Kayel Medichem Private Limited | ₹26.93 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Neomi Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals Private Limited is audited by J P GOSHER & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J P GOSHER & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jetal Amit Sota | Director | 06 Feb 2016 | 10 Years 8 Months | Current |
| Amit Rajnikant Sota | Director | 06 Feb 2016 | 10 Years 8 Months | Current |
Ownership and Shareholding of Neomi Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
MSME Payment Delays by Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Zeiss Pharmaceuticals Private Limited | •••• | •••• | •••• |
| Centurion Remedies Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals operates one associated brand: Neomi Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical and nutraceutical formulations with a focus on quality and global supply. | neomipharma.com |
Employees and EPFO Compliance at Neomi Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Neomi Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals has one previous CIN (Corporate Identification Number): U74120MH2016PTC272811. The current CIN is U46497MH2016PTC272811, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U46497MH2016PTC272811 | Current |
| U74120MH2016PTC272811 | Previous |
Recent Activity on Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Amit Rajnikant Sota was appointed as Director on 06 Feb 2016.
Credit Ratings, Litigation & Regulatory Alerts for Neomi Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Neomi Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCN1442H1ZM | Maharashtra | Active | 22 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Neomi Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neomi Pharmaceuticals Private Limited
Neomi Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 February 2016 (10+ years old) and is registered under CIN U46497MH2016PTC272811.
Neomi Pharmaceuticals reported revenue of ₹27.11 Cr for FY 2025 (down 12% YoY).
Neomi Pharmaceuticals has 2 current directors:
- Jetal Amit Sota - Director
- Amit Rajnikant Sota - Director
Neomi Pharmaceuticals reported a net profit of ₹44.68 Lakh (net margin 1.6%) and EBITDA of ₹72.74 Lakh (EBITDA margin 2.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Neomi Pharmaceuticals is 38% over three years and 60% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Neomi Pharmaceuticals is 27AAFCN1442H1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Neomi Pharmaceuticals is U46497MH2016PTC272811. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neomi Pharmaceuticals was incorporated on 06 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Neomi Pharmaceuticals by revenue are Nexus Lifecare Private Limited, Sun Moon Pharmaceuticals Private Limited, Hiya Healthcare Private Limited, Cibeles Pharmaceuticals Private Limited, Dipali Enterprises Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Amit Rajnikant Sota was appointed as Director on 06 Feb 2016. Jetal Amit Sota was appointed as Director on 06 Feb 2016.
Neomi Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. The latest return was filed on 01 Jun 2019.
Neomi Pharmaceuticals can be reached through the website neomipharma.com. Its registered office is in Mumbai, Maharashtra, India.